Vollenberg, R.; Tepasse, P.-R.; Kühn, J.E.; Hennies, M.; Strauss, M.; Rennebaum, F.; Schomacher, T.; Boeckel, G.; Lorentzen, E.; Bokemeyer, A.;
et al. Humoral Immune Response in IBD Patients Three and Six Months after Vaccination with the SARS-CoV-2 mRNA Vaccines mRNA-1273 and BNT162b2. Biomedicines 2022, 10, 171.
https://doi.org/10.3390/biomedicines10010171
AMA Style
Vollenberg R, Tepasse P-R, Kühn JE, Hennies M, Strauss M, Rennebaum F, Schomacher T, Boeckel G, Lorentzen E, Bokemeyer A,
et al. Humoral Immune Response in IBD Patients Three and Six Months after Vaccination with the SARS-CoV-2 mRNA Vaccines mRNA-1273 and BNT162b2. Biomedicines. 2022; 10(1):171.
https://doi.org/10.3390/biomedicines10010171
Chicago/Turabian Style
Vollenberg, Richard, Phil-Robin Tepasse, Joachim Ewald Kühn, Marc Hennies, Markus Strauss, Florian Rennebaum, Tina Schomacher, Göran Boeckel, Eva Lorentzen, Arne Bokemeyer,
and et al. 2022. "Humoral Immune Response in IBD Patients Three and Six Months after Vaccination with the SARS-CoV-2 mRNA Vaccines mRNA-1273 and BNT162b2" Biomedicines 10, no. 1: 171.
https://doi.org/10.3390/biomedicines10010171
APA Style
Vollenberg, R., Tepasse, P.-R., Kühn, J. E., Hennies, M., Strauss, M., Rennebaum, F., Schomacher, T., Boeckel, G., Lorentzen, E., Bokemeyer, A., & Nowacki, T. M.
(2022). Humoral Immune Response in IBD Patients Three and Six Months after Vaccination with the SARS-CoV-2 mRNA Vaccines mRNA-1273 and BNT162b2. Biomedicines, 10(1), 171.
https://doi.org/10.3390/biomedicines10010171